Active	Status	Sponsor type	Region	Phase	Filter
3 Active 6 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schwartz, Alan
VICTORION-2P, NCT05030428: Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease	Active, not recruiting	3	17004	Europe, Canada, Japan, US, RoW	Inclisiran sodium 300 mg, Placebo	Novartis Pharmaceuticals	Atherosclerotic Cardiovascular Disease	10/27	10/27
THN3, NCT02263859: Targeted Hypoglossal Neurostimulation Study #3	Completed	N/A	138	Europe, US, RoW	aura6000 System, THN Therapy, ImThera Medical	ImThera Medical, Inc., LivaNova	Obstructive Sleep Apnea	06/19	09/23
NCT06093633: A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders	Recruiting	N/A	600	US, RoW		Itamar-Medical, Israel	Sleep Disorder	01/25	01/25